Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference.
We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.
We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.
Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.
Our scientists may have uncovered the 'guidance system' needed to make cancer immunotherapy more effective.
Scientists have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system.
From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.
We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.
We explore today's headlines about new US research on immunotherapy for blood cancers.
We explore a new revolutionary gene editing technology called CRISPR that's taking labs by storm as scientists look to understand the genetics behind cancer.